Coronary risk factors and their modification: Lipids, smoking, hypertension, estrogen, and the elderly
References (193)
Plaque stabilization: a mechanism for the beneficial effect of lipid lowering therapies in angiography studies
Prog Cardiovasc Dis
(1994)- et al.
Beneficial effects of colestipol-niacin on coronary atherosclerosis: a 4-year follow-up
JAMA
(1990) - et al.
Coronary angiographic changes with lovastatin therapy: the Monitored Atherosclerosis Regression Study (MARS)
Ann Intern Med
(1993) - et al.
Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis
Circulation
(1991) - et al.
Alloxan-induced diabetes mellitus impairs endothelium dependent vasodilation of canine coronary arterioles
Circulation
(1994) - et al.
Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction
J Am Coll Cardiol
(1994) - et al.
Plaque fissuring — the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina
Br Heart J
(1985) - et al.
Natural history of coronary atherosclerosis using quantitative angiography in men, and implication for clinical trials of coronary regression
Am J Cardiol
(1993) - et al.
Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients
Lancet
(1994) - et al.
Impact of intensive lipid modulation on angiographically defined coronary disease: clinical implications
South Med J
(1994)
Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)
JAMA
(1986)
Risk factors for peripheral atherosclerosis: retrospective evaluation by stepwise discriminant analysis
Arteriosclerosis
(1983)
Lipoprotein (a) and peripheral vascular disease
J Intern Med
(1992)
Prevalence of carotid atherosclerosis and serum cholesterol levels in Eastern Finland
Arteriosclerosis
(1988)
Beneficial effects of colestipol-niacin therapy on the common carotid artery: two-and four-year reduction of intima-media thickness measured by ultrasound
Circulation
(1993)
Trial of clofibrate in the treatment of ischaemic heart disease
BMJ
(1971)
Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC 1)
J Am Coll Cardiol
(1994)
Advances in LDL apheresis for the treatment of severe hypercholesterolemia
Curr Opin Lipidol
(1994)
Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data
BMJ
(1989)
Fibrinogen: its emerging role as a cardiovascular risk factor
Angiology
(1994)
Epidemiology of atherosclerotic diseases in population groups
The Lipid Research Clinics Primary Prevention Trial results
JAMA
(1984)
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study
JAMA
(1988)
The value of lowering cholesterol after myocardial infarction
N Engl J Med
(1990)
Risk factor modification after myocardial infarction
Ann Intern Med
(1988)
Fifteen year mortality in coronary drug project patients: long-term benefits with niacin
J Am Coll Cardiol
(1980)
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
N Engl J Med
(1990)
Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Lancet
(1994)
Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected or proven coronary artery disease
Circulation
(1991)
Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease
Circulation
(1993)
The pathogenesis of coronary artery disease and the acute coronary syndromes
N Engl J Med
(1992)
et al.The pathogenesis of coronary artery disease and the acute coronary syndromes
N Engl J Med
(1992)
Toward the quiescent coronary plaque
J Am Coll Cardiol
(1993)
Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)
N Engl J Med
(1990)
Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens
JAMA
(1990)
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS)
Lancet
(1992)
Macrophage infiltration in acute coronary syndromes: implications for plaque rupture
Circulation
(1993)
Coronary artery disease regression: convincing evidence for the benefit of aggressive lipoprotein management
Circulation
(1994)
Regulatory function of the vascular endothelium
N Engl J Med
(1990)
Endothelium-derived relaxing factor and coronary vasospasm
Circulation
(1989)
Control of shear stress in the epicardial coronary arteries of humans: impairment by atherosclerosis
J Am Coll Cardiol
(1989)
Cardiovascular effects of acute hypercholesteroemia in rabbits: reversal with lovastatin treatment
J Clin Invest
(1989)
Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients
Lancet
(1993)
Flow-dependent vasodilation of brachial artery in essential hypertension
Am J Physiol
(1990)
Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults
Circulation
(1993)
Nitric oxide accounts for dose-dependant estrogen-mediated coronary relaxation after acute estrogen withdrawal
Circulation
(1994)
Coronary endothelial responses are improved with aggressive lipid lowering therapy in patients with atherosclerosis
Circulation
(1993)
Cholesterol lowering therapy im- proves endothelial function in patients with coronary atherosclerosis
Circulation
(1993)
Cited by (17)
Disorders of Lipid Metabolism and Chronic Kidney Disease in the Elderly
2009, Seminars in NephrologyCitation Excerpt :Thus, declining renal function in the elderly may increase the burden of cardiovascular risk. Approximately 33% of elderly men and 50% of elderly women have a total cholesterol level greater than 240.56 A greater prevalence of metabolic syndrome including central obesity with insulin resistance, increased blood pressure, and dyslipidemia characterized by increased triglyceride levels, small high dense LDL, and a low concentration of HDL is being noted in older adults.57,58
Smoking in Saudi Arabia and its relation to coronary artery disease
2009, Journal of the Saudi Heart AssociationWomen's Initiative for Non-Smoking (WINS) VI: Reliability and validity of health and psychosocial measures in women smokers with cardiovascular disease
2004, Heart and Lung: Journal of Acute and Critical CarePrevalence of coronary artery disease and its associated risk factors in Aljouf region of Saudi Arabia
2022, Bangladesh Journal of Medical ScienceRelationship of time-activity-adjusted particle number concentration with blood pressure
2018, International Journal of Environmental Research and Public Health
Copyright © 1995 Published by Elsevier Inc.